These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25887882)

  • 1. Review: The role of paraoxonase in cardiovascular diseases.
    Kowalska K; Socha E; Milnerowicz H
    Ann Clin Lab Sci; 2015; 45(2):226-33. PubMed ID: 25887882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase and atherosclerosis-related cardiovascular diseases.
    Chistiakov DA; Melnichenko AA; Orekhov AN; Bobryshev YV
    Biochimie; 2017 Jan; 132():19-27. PubMed ID: 27771368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paraoxonase 1, 2 and 3 in humans.
    Rajkovic MG; Rumora L; Barisic K
    Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonases-1, -2 and -3: What are their functions?
    Furlong CE; Marsillach J; Jarvik GP; Costa LG
    Chem Biol Interact; 2016 Nov; 259(Pt B):51-62. PubMed ID: 27238723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention.
    Mackness MI; Durrington PN; Mackness B
    Am J Cardiovasc Drugs; 2004; 4(4):211-7. PubMed ID: 15285696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
    AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
    Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase gene polymorphisms and haplotype analysis in a stroke population.
    Pasdar A; Ross-Adams H; Cumming A; Cheung J; Whalley L; St Clair D; MacLeod MJ
    BMC Med Genet; 2006 Mar; 7():28. PubMed ID: 16551349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
    Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of PON1 and PON2 in cardiovascular disease and innate immunity.
    Shih DM; Lusis AJ
    Curr Opin Lipidol; 2009 Aug; 20(4):288-92. PubMed ID: 19474728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paraoxonase: The Universal Factor of Antioxidant Defense in Human Body].
    Borovkova EI; Antipova NV; Komeenko TV; Shakhparonov MI; Borovkov IM
    Vestn Ross Akad Med Nauk; 2017; 72(1):5-10. PubMed ID: 29308836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti-High-Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease.
    Rodríguez-Carrio J; López-Mejías R; Alperi-López M; López P; Ballina-García FJ; González-Gay MÁ; Suárez A
    Arthritis Rheumatol; 2016 Jun; 68(6):1367-76. PubMed ID: 26815637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, infection, cancer and all that…the role of paraoxonases.
    Devarajan A; Shih D; Reddy ST
    Adv Exp Med Biol; 2014; 824():33-41. PubMed ID: 25038992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paraoxonase--important enzyme of the lipid metabolism and potential ally in the antiatherosclerotic treatment].
    Sapian-Raczkowska B; Rabczyński M; Adamiec R
    Pol Merkur Lekarski; 2010 Nov; 29(173):325-7. PubMed ID: 21268919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in paraoxonase-1 activity and atherosclerosis.
    Soran H; Younis NN; Charlton-Menys V; Durrington P
    Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus.
    Dasgupta S; Demirci FY; Dressen AS; Kao AH; Rhew EY; Ramsey-Goldman R; Manzi S; Kammerer CM; Kamboh MI
    BMC Med Genet; 2011 Jan; 12():7. PubMed ID: 21223581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase (PON) 1, 2 and 3 expression in granulosa cells and PON1 activity in follicular fluid of dairy cows.
    Schneider A; Absalon-Medina VA; Esposito G; Corrêa MN; Butler WR
    Reprod Domest Anim; 2013 Dec; 48(6):989-94. PubMed ID: 23758560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paraoxonase gene family and atherosclerosis.
    Ng CJ; Shih DM; Hama SY; Villa N; Navab M; Reddy ST
    Free Radic Biol Med; 2005 Jan; 38(2):153-63. PubMed ID: 15607899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase.
    Otocka-Kmiecik A; Orłowska-Majdak M
    Postepy Hig Med Dosw (Online); 2009 Dec; 63():668-77. PubMed ID: 20097953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.